FDA Proposes Withdrawal of Low Blood Pressure Drug
The U.S. Food and Drug Administration proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done.
Original Source of FDA Proposes Withdrawal of Low Blood Pressure Drug
